Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
Is a |
Product containing methyltestosterone and pemoline and yohimbine (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Hormone |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Pemoline (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Yohimbine |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Methyltestosterone (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Stimulant (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Alpha-2 adrenergic receptor antagonist |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Anabolic androgenic steroid |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has manufactured dose form |
A solid single-dose form that is a shell made of gelatin or other substances. The contents of the shell may be a solid, semi-solid or liquid. |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
Is a |
Product containing testosterone in oral dose form (medicinal product form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has manufactured dose form |
Oral capsule |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Pemoline (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
Pemoline (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator value |
dix |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator unit (attribute) |
mg |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator value |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
Capsule (unit of presentation) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator value |
cinq |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator unit (attribute) |
mg |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator value |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
Capsule (unit of presentation) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator value |
cinq |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator unit (attribute) |
mg |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator value |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
Capsule (unit of presentation) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
Yohimbine |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator value |
cinq |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Yohimbine |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
Yohimbine |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Methyltestosterone (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
Methyltestosterone (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
Pemoline (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator value |
dix |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
Pemoline (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
Capsule (unit of presentation) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
Methyltestosterone (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
Yohimbine |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
Is a |
Methyltestosterone- and pemoline- and yohimbine-containing product in oral dose form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
Count of base of active ingredient |
trois |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
Is a |
Methyltestosterone and pemoline and yohimbine only product in oral dose form |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
Methyltestosterone (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
Yohimbine |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
Methyltestosterone (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
Yohimbine |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|